317 related articles for article (PubMed ID: 24789530)
21. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.
Ito Y; Nakamura M; Yamakoshi T; Lin J; Yatsuya H; Terasaki H
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4079-86. PubMed ID: 17724190
[TBL] [Abstract][Full Text] [Related]
22. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease.
Garcia-Martin E; Satue M; Fuertes I; Otin S; Alarcia R; Herrero R; Bambo MP; Fernandez J; Pablo LE
Ophthalmology; 2012 Oct; 119(10):2161-7. PubMed ID: 22749083
[TBL] [Abstract][Full Text] [Related]
23. Venturing into the no-man's land of the retina in Parkinson's disease.
Bodis-Wollner I; Miri S; Glazman S
Mov Disord; 2014 Jan; 29(1):15-22. PubMed ID: 24339212
[TBL] [Abstract][Full Text] [Related]
24. Foveal vision is impaired in Parkinson's disease.
Bodis-Wollner I
Parkinsonism Relat Disord; 2013 Jan; 19(1):1-14. PubMed ID: 22998939
[TBL] [Abstract][Full Text] [Related]
25. Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia.
Pillai JA; Bermel R; Bonner-Jackson A; Rae-Grant A; Fernandez H; Bena J; Jones SE; Ehlers JP; Leverenz JB
Am J Alzheimers Dis Other Demen; 2016 Aug; 31(5):430-6. PubMed ID: 26888864
[TBL] [Abstract][Full Text] [Related]
26. Retinal nerve fiber layer thinning in Parkinson disease.
Inzelberg R; Ramirez JA; Nisipeanu P; Ophir A
Vision Res; 2004 Nov; 44(24):2793-7. PubMed ID: 15342223
[TBL] [Abstract][Full Text] [Related]
27. Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study.
Polo V; Satue M; Rodrigo MJ; Otin S; Alarcia R; Bambo MP; Fuertes MI; Larrosa JM; Pablo LE; Garcia-Martin E
BMJ Open; 2016 May; 6(5):e009658. PubMed ID: 27154474
[TBL] [Abstract][Full Text] [Related]
28. Progressive Changes in the Retinal Structure of Patients with Parkinson's Disease.
Ma LJ; Xu LL; Mao CJ; Fu YT; Ji XY; Shen Y; Chen J; Yang YP; Liu CF
J Parkinsons Dis; 2018; 8(1):85-92. PubMed ID: 29480221
[TBL] [Abstract][Full Text] [Related]
29. In vivo exploration of retinal nerve fiber layer morphology in Parkinson's disease patients.
Visser F; Vermeer KA; Ghafaryasl B; Vlaar AMM; Apostolov V; van Hellenberg Hubar J; Weinstein HC; de Boer JF; Berendse HW
J Neural Transm (Vienna); 2018 Jun; 125(6):931-936. PubMed ID: 29520613
[TBL] [Abstract][Full Text] [Related]
30. Is retina affected in Huntington's disease? Is optical coherence tomography a good biomarker?
Dusek P; Kopal A; Brichova M; Roth J; Ulmanova O; Klempir J; Preiningerova JL
PLoS One; 2023; 18(2):e0282175. PubMed ID: 36827300
[TBL] [Abstract][Full Text] [Related]
31. Retinal pathology detected by optical coherence tomography in an animal model of Parkinson's disease.
Schneider JS; Ault ME; Anderson DW
Mov Disord; 2014 Oct; 29(12):1547-51. PubMed ID: 25070726
[TBL] [Abstract][Full Text] [Related]
32. Self-perception and determinants of color vision in Parkinson's disease.
Brandt AU; Zimmermann HG; Oberwahrenbrock T; Isensee J; Müller T; Paul F
J Neural Transm (Vienna); 2018 Feb; 125(2):145-152. PubMed ID: 29143216
[TBL] [Abstract][Full Text] [Related]
33. Macular morphology in patients with optic nerve head drusen and optic disc edema.
Pilat AV; Proudlock FA; Kumar P; Lee H; Papageorgiou E; Gottlob I
Ophthalmology; 2014 Feb; 121(2):552-7. PubMed ID: 24238882
[TBL] [Abstract][Full Text] [Related]
34. In Vivo Morphology of the Optic Nerve and Retina in Patients With Parkinson's Disease.
Pilat A; McLean RJ; Proudlock FA; Maconachie GD; Sheth V; Rajabally YA; Gottlob I
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4420-4427. PubMed ID: 27750285
[TBL] [Abstract][Full Text] [Related]
35. Three-dimensional imaging of the macular retinal nerve fiber layer in glaucoma with spectral-domain optical coherence tomography.
Sakamoto A; Hangai M; Nukada M; Nakanishi H; Mori S; Kotera Y; Inoue R; Yoshimura N
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5062-70. PubMed ID: 20463326
[TBL] [Abstract][Full Text] [Related]
36. Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity.
Garcia-Martin E; Rodriguez-Mena D; Satue M; Almarcegui C; Dolz I; Alarcia R; Seral M; Polo V; Larrosa JM; Pablo LE
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):696-705. PubMed ID: 24425856
[TBL] [Abstract][Full Text] [Related]
37. Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.
Moreno-Ramos T; Benito-León J; Villarejo A; Bermejo-Pareja F
J Alzheimers Dis; 2013; 34(3):659-64. PubMed ID: 23271313
[TBL] [Abstract][Full Text] [Related]
38. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease.
Altintaş O; Işeri P; Ozkan B; Cağlar Y
Doc Ophthalmol; 2008 Mar; 116(2):137-46. PubMed ID: 17962989
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography.
Marziani E; Pomati S; Ramolfo P; Cigada M; Giani A; Mariani C; Staurenghi G
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):5953-8. PubMed ID: 23920375
[TBL] [Abstract][Full Text] [Related]
40. Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.
Bertrand JA; Bedetti C; Postuma RB; Monchi O; Génier Marchand D; Jubault T; Gagnon JF
Mov Disord; 2012 Dec; 27(14):1781-8. PubMed ID: 23147270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
